State Street Corp Sellas Life Sciences Group, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, State Street Corp holds 97,129 shares of SLS stock, worth $115,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,129
Previous 97,129
-0.0%
Holding current value
$115,583
Previous $102,000
3.92%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SLS
# of Institutions
35Shares Held
8.03MCall Options Held
2.52MPut Options Held
24.7K-
Anson Funds Management LP Dallas, TX4.83MShares$5.75 Million0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.8 Million0.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$367,0743.71% of portfolio
-
Black Rock Inc. New York, NY278KShares$331,0790.0% of portfolio
-
Geode Capital Management, LLC Boston, MA273KShares$324,9440.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24.5M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...